NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/05/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization180.29 mln
Earnings Date06/02/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.48
Borderline
Relative Strength
5
/ 100
Severely lagging
Debt / Equity
0.08
Debt-free
ROE
-9.93
Negative
Dividend Yield
0.00%
No dividend
Business Description
Burning Rock Biotech, founded in 2014 and based in Guangzhou, China, develops advanced genetic testing tools that help doctors choose the right cancer treatments for their patients. The company serves hospitals, independent laboratories, and pharmaceutical companies across China and the United States, offering tests that analyze tumor DNA from both tissue and blood samples across a wide range of cancer types. It also partners with major global pharmaceutical companies to support clinical trials and drug development research.
